Cynata Therapeutics Limited carries a market capitalization of 54.17M, placing it among publicly traded companies globally.
| Market Cap | 54.17M |
| Enterprise Value | N/A |
Cynata Therapeutics Limited's stock has gained approximately 48.33333% over the past 52 weeks. The 50-day moving average sits at 0.22, while the 200-day moving average is 0.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 48.33333% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.17 |
| Average Volume (20 Days) | N/A |